The Covid-19 Outpatient Symptom Montelukast Oximetry Trial
NCT04389411
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
250
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Montelukast 10mg
Sponsor
McGill University
Collaborators
[object Object]
[object Object]
[object Object]